ECT-001-CB
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ECT-001-CB, covering 2026-03-24 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies [Phase 1, Phase 2]